Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Abroad (travel likely)RecruitingPHASE4

Conditions

Castration Resistant Prostate Cancer · Castration Sensitive Prostate Cancer · Prostate Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

OHSU Knight Cancer Institute, Portland, Oregon, United States
Contact: Study coordinator (Lauren Drake) · RADResearch@ohsu.edu · 503-494-4960
Contact: Principal Investigator (Nadine Mallak, MD)

Study leads

Nadine Mallak, MD
Principal Investigator
OHSU Knight Cancer Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Prostate Cancer

Abroad (travel likely)RecruitingPHASE3

Palo Alto, United States · Santa Barbara, United States

Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer

Prostate Cancer

Abroad (travel likely)RecruitingPHASE3

Olomouc, Czechia · Villejuif, France

Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

Abroad (travel likely)RecruitingPHASE1

Brooklyn, United States · New York, United States

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

Metastatic Prostate Cancer · Prostate Cancer

Abroad (travel likely)RecruitingPHASE1

San Francisco, United States